Recruiting Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer NCT05485766 Conditions BRCA Mutation, BRCA-Associated Breast Carcinoma, BRCA1 Mutation, +11 more Locations Gifu University Hospital — Gifu, Japan Okayama University Hospital — Okayama, Japan St. Luke's International Hospital — Tokyo, Japan View Trial Details
